Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 (DBCOND0109681)
Identifiers
- Synonyms
- Not Available
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT00720109 Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia - Asparaginase Escherichia coli
- Aspartic acid
- Beta-D-Glucose
- Calcium
- Cortisone
- Cyclophosphamide
- Cytarabine
- Dasatinib
- Daunorubicin
- Dexamethasone
- Ethanol
- Etoposide
- Filgrastim
- Hydrocortisone
- Hydrocortisone succinate
- Ifosfamide
- Leucovorin
- Levoleucovorin
- Mercaptopurine
- Methopterin
- Methotrexate
- Methylprednisolone
- Pegaspargase
- Prednisone
- Sodium succinate
- Sulfate ion
- Vincristine
treatment 2 / 3 completed NCT01190930 Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma treatment 3 active_not_recruiting NCT00036738 Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib treatment 2 completed